Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1170226.RANBa49xm1M3g7I5fmJ1ML-MRroKFOh8WNbh-07wDV1ZM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1170226.RANBa49xm1M3g7I5fmJ1ML-MRroKFOh8WNbh-07wDV1ZM130_assertion type Assertion NP1170226.RANBa49xm1M3g7I5fmJ1ML-MRroKFOh8WNbh-07wDV1ZM130_head.
- NP1170226.RANBa49xm1M3g7I5fmJ1ML-MRroKFOh8WNbh-07wDV1ZM130_assertion description "[We identified the glycogen debranching enzyme AGL as a prognostic indicator of patient survival (P = .04) and as a novel regulator of bladder cancer anchorage-dependent (P < .001), anchorage-independent (mean � standard deviation, 180 � 23.1 colonies vs 20�9.5 in control, P < .001), and xenograft growth (P < .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1170226.RANBa49xm1M3g7I5fmJ1ML-MRroKFOh8WNbh-07wDV1ZM130_provenance.
- NP1170226.RANBa49xm1M3g7I5fmJ1ML-MRroKFOh8WNbh-07wDV1ZM130_assertion evidence source_evidence_literature NP1170226.RANBa49xm1M3g7I5fmJ1ML-MRroKFOh8WNbh-07wDV1ZM130_provenance.
- NP1170226.RANBa49xm1M3g7I5fmJ1ML-MRroKFOh8WNbh-07wDV1ZM130_assertion SIO_000772 24700805 NP1170226.RANBa49xm1M3g7I5fmJ1ML-MRroKFOh8WNbh-07wDV1ZM130_provenance.
- NP1170226.RANBa49xm1M3g7I5fmJ1ML-MRroKFOh8WNbh-07wDV1ZM130_assertion wasDerivedFrom befree-2016 NP1170226.RANBa49xm1M3g7I5fmJ1ML-MRroKFOh8WNbh-07wDV1ZM130_provenance.
- NP1170226.RANBa49xm1M3g7I5fmJ1ML-MRroKFOh8WNbh-07wDV1ZM130_assertion wasGeneratedBy ECO_0000203 NP1170226.RANBa49xm1M3g7I5fmJ1ML-MRroKFOh8WNbh-07wDV1ZM130_provenance.